Literature DB >> 3391648

Studies on the adjuvant action of beryllium. III. The activity in the plasma of lymph efferent from nodes stimulated with beryllium.

S Denham1, J G Hall.   

Abstract

Efferent lymph from the popliteal or prefemoral lymph nodes was collected from unanaesthetized sheep before and after the injection of insoluble Be(OH)2 into the subcuticulum that was drained by the nodes. Sterile, cell-free plasma from lymph collected during the 48 hr after the injections, induced vigorous lympho-proliferative responses in naive lymph nodes after s.c. injection into autochthonous or allogeneic recipients. The same lymph had an adjuvant action when injected i.p. into both nude and euthymic rats. Many samples of such lymph were screened for biological activity in rats by noting the increase in the weight of the regional popliteal nodes that occurred after the test sample had been injected into the footpad. All the active samples were shown, by atomic absorbance spectroscopy, to contain beryllium, and we concluded that this metal, in the form of soluble Be-protein adducts, was probably the prime mover in all the observed responses.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3391648      PMCID: PMC1384966     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  3 in total

1.  Studies in immunization. 3. The use of beryllium as a granuloma-producing agent in Freund's adjuvant.

Authors:  J E Salvaggio; M H Flax; S Leskowitz
Journal:  J Immunol       Date:  1965-11       Impact factor: 5.422

2.  Studies on the adjuvant action of beryllium. II. Systemic effects with particular reference to secretory immunity.

Authors:  J G Hall; J Spencer
Journal:  Immunology       Date:  1984-09       Impact factor: 7.397

3.  Studies on the adjuvant action of beryllium. I. Effects on individual lymph nodes.

Authors:  J G Hall
Journal:  Immunology       Date:  1984-09       Impact factor: 7.397

  3 in total
  4 in total

1.  Expression of CD45R0 (UCHL1) by CD4+ and CD8+ T cells as a sign of in vivo activation in infectious mononucleosis.

Authors:  T Miyawaki; Y Kasahara; H Kanegane; K Ohta; T Yokoi; A Yachie; N Taniguchi
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

2.  Preferential expression of IL-2 receptor subunits on memory populations within CD4+ and CD8+ T cells.

Authors:  K Taga; Y Kasahara; A Yachie; T Miyawaki; N Taniguchi
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

Review 3.  Adaptive Immunity in Pulmonary Sarcoidosis and Chronic Beryllium Disease.

Authors:  Sarah A Greaves; Shaikh M Atif; Andrew P Fontenot
Journal:  Front Immunol       Date:  2020-03-18       Impact factor: 7.561

4.  Skin as a route of exposure and sensitization in chronic beryllium disease.

Authors:  Sally S Tinkle; James M Antonini; Brenda A Rich; Jenny R Roberts; Rebecca Salmen; Karyn DePree; Eric J Adkins
Journal:  Environ Health Perspect       Date:  2003-07       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.